Physician profile
Rolando E Gonzalez
NPI 1548464944
$758.91
in general payments reported to CMS, 2019-2025
16 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.85 · 2020: $37.42 · 2021: $38.39 · 2022: $16.67 · 2023: $240 · 2024: $58.32 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $282.51 | 2025 | |
| Dexcom, INC. | $129.00 | 2023 | Dexcom G7 Gss (161) |
| Exact Sciences Corporation | $45.17 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.90 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $38.79 | 2024-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $29.87 | 2021-2024 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $24.28 | 2020 | |
| Alkermes, INC. | $23.26 | 2023 | Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.28 | 2021 | |
| Organon LLC | $21.80 | 2023 | Nexplanon, Nuvaring |
| Shield Therapeutics INC | $18.55 | 2023 | Accrufer |
| Qiagen, LLC | $16.99 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.67 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.85 | 2019 | |
| Pfizer INC. | $15.85 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.